183 related articles for article (PubMed ID: 37648724)
1. A comparative study of posterior cingulate metabolism in patients with mild cognitive impairment due to Parkinson's disease or Alzheimer's disease.
Huang M; Yu H; Cai X; Zhang Y; Pu W; Gao B
Sci Rep; 2023 Aug; 13(1):14241. PubMed ID: 37648724
[TBL] [Abstract][Full Text] [Related]
2. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Waragai M; Moriya M; Nojo T
J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
[TBL] [Abstract][Full Text] [Related]
3. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
4. Region-specific Cerebral Metabolic Alterations in Parkinson's Disease Patients With/without Mild Cognitive Impairment.
Huang M; Yu H; Lyu X; Pu W; Yin J; Gao B
Neuroscience; 2024 Jun; 551():254-261. PubMed ID: 38848776
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.
Babiloni C; Del Percio C; Lizio R; Noce G; Cordone S; Lopez S; Soricelli A; Ferri R; Pascarelli MT; Nobili F; Arnaldi D; Famà F; Aarsland D; Orzi F; Buttinelli C; Giubilei F; Onofrj M; Stocchi F; Stirpe P; Fuhr P; Gschwandtner U; Ransmayr G; Caravias G; Garn H; Sorpresi F; Pievani M; D'Antonio F; De Lena C; Güntekin B; Hanoğlu L; Başar E; Yener G; Emek-Savaş DD; Triggiani AI; Franciotti R; Frisoni GB; Bonanni L; De Pandis MF
J Alzheimers Dis; 2017; 59(1):339-358. PubMed ID: 28621693
[TBL] [Abstract][Full Text] [Related]
6. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
7. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
[TBL] [Abstract][Full Text] [Related]
8. Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study.
Reyngoudt H; Claeys T; Vlerick L; Verleden S; Acou M; Deblaere K; De Deene Y; Audenaert K; Goethals I; Achten E
Eur J Radiol; 2012 Mar; 81(3):e223-31. PubMed ID: 21345628
[TBL] [Abstract][Full Text] [Related]
9. Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer's and Parkinson's diseases.
Babiloni C; Del Percio C; Lizio R; Noce G; Lopez S; Soricelli A; Ferri R; Pascarelli MT; Catania V; Nobili F; Arnaldi D; Famà F; Orzi F; Buttinelli C; Giubilei F; Bonanni L; Franciotti R; Onofrj M; Stirpe P; Fuhr P; Gschwandtner U; Ransmayr G; Garn H; Fraioli L; Pievani M; D'Antonio F; De Lena C; Güntekin B; Hanoğlu L; Başar E; Yener G; Emek-Savaş DD; Triggiani AI; Taylor JP; De Pandis MF; Vacca L; Frisoni GB; Stocchi F
Clin Neurophysiol; 2018 Apr; 129(4):766-782. PubMed ID: 29448151
[TBL] [Abstract][Full Text] [Related]
10. Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla.
Oeltzschner G; Wijtenburg SA; Mikkelsen M; Edden RAE; Barker PB; Joo JH; Leoutsakos JS; Rowland LM; Workman CI; Smith GS
Neurobiol Aging; 2019 Jan; 73():211-218. PubMed ID: 30390554
[TBL] [Abstract][Full Text] [Related]
11. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia.
Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
Alzheimers Dement; 2008 Nov; 4(6):421-7. PubMed ID: 19012867
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the posterior cingulate cortex with [18F]FDG-PET and Naa/mI in mild cognitive impairment and Alzheimer's disease: Correlations and differences between the two methods.
Coutinho AMN; Porto FHG; Zampieri PF; Otaduy MC; Perroco TR; Oliveira MO; Nunes RF; Pinheiro TL; Bottino CMC; Leite CC; Buchpiguel CA
Dement Neuropsychol; 2015; 9(4):385-393. PubMed ID: 29213988
[TBL] [Abstract][Full Text] [Related]
13. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
[TBL] [Abstract][Full Text] [Related]
14. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W
Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359
[TBL] [Abstract][Full Text] [Related]
15. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.
Olson BL; Holshouser BA; Britt W; Mueller C; Baqai W; Patra S; Petersen F; Kirsch WM
Alzheimer Dis Assoc Disord; 2008; 22(3):269-77. PubMed ID: 18580584
[TBL] [Abstract][Full Text] [Related]
17. Detection and application of neurochemical profile by multiple regional
Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
[TBL] [Abstract][Full Text] [Related]
18. Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment.
Chaudhary S; Kumaran SS; Goyal V; Kalaivani M; Kaloiya GS; Sagar R; Mehta N; Srivastava AK; Jagannathan NR
Neurol Sci; 2021 Mar; 42(3):1053-1064. PubMed ID: 32729012
[TBL] [Abstract][Full Text] [Related]
19. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
20. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
